Seeking to boost shareholder returns, Novartis readies new $11B buyback round aliu Mon, 03/13/2023 – 11:07 More: Seeking to boost shareholder returns, Novartis readies new B buyback round Source: fierce
read moreWith $43B buyout, Pfizer sees cancer specialist Seagen as a ‘goose’ laying ‘golden eggs’ kdunleavy Mon, 03/13/2023 – 10:16 More: With B buyout, Pfizer sees cancer specialist Seagen as a 'goose' laying 'golden eggs' Source: fierce
read moreAcadia’s Daybue wins FDA nod as first treatment for Rett syndrome esagonowsky Mon, 03/13/2023 – 09:28 More: Acadia's Daybue wins FDA nod as first treatment for Rett syndrome Source: fierce
read moreSanofi throws down $2.9B to acquire diabetes partner Provention Bio fkansteiner Mon, 03/13/2023 – 09:05 More: Sanofi throws down .9B to acquire diabetes partner Provention Bio Source: fierce
read moreNorfolk and Norwich University Hospitals have been using two Mostcare Up devices since 2019 More: Vygon monitors provide improvement for ovarian cancer patients Source: News
read moreThe type 2 diabetes therapy is being tested on patients in a phase 2 clinical trial More: IIH headaches could be treated with exenatide Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals